Adoptive transfer of cytotoxic T lymphocytes induced by CD86- transfected tumor cells suppresses multi-organ metastases of C1300 neuroblastoma in mice

Cancer Immunology Immunotherapy

Volumn 44, Issue 4, 1997, Pages 204-210

  Enomoto, Ayako ^a   Kato, Kazunori ^a   Yagita, Hideo ^a   Okumura, Ko ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Adoptive immunotherapy; CD86; Cytotoxic T lymphocytes; Metastasis; Neuroblastoma

Indexed keywords

CD86 ANTIGEN; RECOMBINANT INTERLEUKIN 2;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; LYMPHOCYTE TRANSFER; METASTASIS; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD8; ANTIGENS, CD86; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOTHERAPY, ADOPTIVE; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-2; KIDNEY NEOPLASMS; LIVER NEOPLASMS; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED A; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; OVARIAN NEOPLASMS; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030742022     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050374     Document Type: Article

References (36)

1. Azuma M, Cayabyab M, Buck D, Phillips JH, Lanier LL (1992) CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J Exp Med 175:353
2. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, Somoza C (1993) B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76
3. Azuma M, Cayabyab M, Phillips JH, Lanier LL (1993) Requirements for CD28-dependent T cell-mediated cytotoxicity. J Immunol 150:2091
4. Blueston JA (1995) New perspectives of CD28-B7-mediated Tcell costimulation. Immunity 2:555
5. Chen L, Ashe S, Brady WA, Hellström I, Hellström KE, Ledbetter JA, McGowan P, Linsley PS (1992) Costimulation of antitumor immunity by the B7 counter-receptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71:1
6. Chen L, Linsley PS, Hellström KE (1993) Costimulation of T cells for tumor immunity. Immunol Today 14:483
7. Chen L, McGowan P, Ashe S, Johnston J, Li Y, Hellström I, Hellström KE (1994) Tumor immunogenicity determines the effect of B7 costimulation on T cell -mediated tumor immunity. J Exp Med 179:523
8. Crowley NJ, Vervaert CE. Seigler HF (1992) Human xenograft -nude mouse model of adoptive immunotherapy with human melanoma-specific cytotoxic T-cells. Cancer Res 52:394
9. Dranoff G, Mulligan RC (1994) Gene transfer as cancer therapy. Adv Immunol 58:417
10. Feltkamp MC, Vreugdenhil GR, Vierhoom MPM, Ras E, van der Burg SH, ter Schegget J, Melief CJM, Martin Kast W (1995) Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors. Eur J Immunol 25:2638
11. Freeman GJ, Boussiotis VA, Anumanthan A, Bernstein GM, Ke X, Rennert PD, Gray GS, Gribhen JG, Nadler LM (1995) B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523
12. Gajewski TF, Fallarino F, Uyttenhove C, Boon T (1996) Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor. J Immunol 156:2909
13. Greenberg PD (1991) Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv Immunol 49:281
14. + cytotoxic T lymphocytes in the absence of exogenous help. J Exp Med 177:1791
15. Hathcock KS, Laszio G, Pucillo C, Linsley P, Hodes RJ (1994) Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med 180:631
16. Hellström KE, Hellström I, Chen L (1995) Can co-stimulated tumor immunity be therapeutically efficacious? Immunol Rev 145:123
17. Inaba K, Witmer-Pack M, Inaba M, Hathcock KS, Sakuta H, Azuma M, Yagita H, Okumura K, Linsley PS, Ikehara S, Muramatu S, Hodes RJ, Steinman RM (1994) The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 180:1849
18. Jenkins MK, Johnson JG (1993) Molecules involved in T cell Co-stimulation. Curr Opin Immunol 5:367
19. June CH, Bluestone JA, Nadler LM, Thompson CB (1994) The B7 and CD28 receptor families. Immunol Today 15:321
20. Kawasaki A, Shinkai Y, Yagita H, Okumura K (1992) Expression of perform in murine natural killer cells and cytotoxic T lymphocytes in vivo. Eur J Immunol 22:1215
21. Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, Azuma M (1995) CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 154:97
22. Linsley PS, Ledbetter JA (1993) The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11:191
23. Martin-Fontecha A, Cavallo F, Bellone M, Heltai S, Iezzi G, Tornaghi P, Nabavi N, Forni G, Dellabona P, Casorati G (1996) Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic anti-tumor immunity against different mouse tumors. Eur J Immunol 26:1851
24. Matulonis U, Dosiou C, Freeman G, Lamont C, Manch P, Nadler LM, Griffin JD (1996) B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell -mediated antileukemia immunity. J Immunol 156:1126
25. Melief CJ (1992) Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv Cancer Res 58:143
26. Muul LM, Spiess PJ, Director EP, Rosenberg SA (1987) Identification of specific cytolytic immune responses against autologous tumor in humans hearing malignant melanoma. J Immunol 138:989
27. Nakajima A, Azuma M, Kodera S, Nuriya S, Terasi A, Abe M, Hirose S, Shirai T, Yagita H, Okumura K (1995) Preferential dependence of autoantibody production in murine lupus on CD86 co-stimulatory molecule. Eur J Immunol 25:3060
28. Ranger AM. Das MP, Kuchroo VK, Glimcher LH (1996) B7-2 (CD86) is essential for the development of IL-4-producing T cells. Int Immunol 8:1549
29. Rosenberg SA, Spiess P, Lafreniere R (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233:1318
30. Sabzevari H, Reisfeld RA (1993) Human cytotoxic T-cells suppress the growth of spontaneous melanoma metastases in SCID/hu mice. Cancer Res 53:4933
31. Schwarz RH (1992) Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BBI in interleukin-2 production and immunotherapy. Cell 71:1065
32. Thompson CB (1995) Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 81:979
33. Topalian SL, Muul LM, Solomon D, Rosenberg SA (1987) Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. J Immunol Methods 102:127
34. Townsend SE, Allison JP (1993) Tumor rejection after direct costimulation of CD8+T cells by B7-transfected melanoma cells. Science 259:368
35. Yang G, Hellström KE, Hellström I, Chen L (1995) Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules. J Immunol 154:2794
36. Wu T, Huang AYC, Jaffee EM, Levitsky HI, Pardoll DM (1995) A reassessment of the role of B7-1 expression in tumor rejection. J Exp Med 182:1415